Abstract
Objective: We aimed to investigate whether Serum levels of glycogen phosphorylase BB (GPBB) isoformcould be used as a potential diagnostic biomarker in Acute Ischemic Stroke (AIS) patients or not.Materials and methods : glycogen phosphorylase BB were prospectively evaluated in 40 patients agedbetween 40 to 70 y who were admitted within 24 h of the onset of AIS. The control group included 40healthy volunteers of similar age without any disease.Results: There is a significant elevation in the level of GPBB in ischemic stroke group and compared withcontrol group. For Control, the observations of GPBB had an Min = 4.91 For Stroke, the observations ofGPBB had an Min = 15.32There was a significant positive correlation between stoke and Glycogen phosphorylase (rpb = 0.7473,p< .001). The correlation coefficient between Stroke and Glycogen phosphorylase was 0.7473 indicatinga large effect size. This indicates that moving from the Not having to having Stroke is associated withan increase in Glycogen phosphorylase. Therefore, Stroke tends to be associated with higher values ofGlycogen phosphorylaseConclusions: 1-This study shows there is significant elevation in enzyme level of glycogen phosphorylaseBB (GPBB) in ischemic stroke group and compared with control group.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Forensic Medicine & Toxicology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
